Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists

被引：5

作者：

Steinhubl, SR ^{[1
]}

机构：

[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA

来源：

CORONARY ARTERY DISEASE | 2003年 / 14卷 / 05期

关键词：

platelets; GP IIb/IIIa antagonists; monitoring;

D O I：

10.1097/00019501-200308000-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：381 / 386

页数：6

共 50 条

[21] Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein, IIb/IIIa antagonists in vitro
Stegnar, Mojca
Bozic, Mojca
Dolenc, Marija Sollner
Anderluh, Petra Stefanic
Kikelj, Danijel
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (11) : 1542 - 1548
[22] Platelet glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions: a pharmacological and clinical review
Anne, G
Gruberg, L
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (02) : 335 - 348
[23] Oral platelet glycoprotein IIb/IIIa receptor inhibitors - Part II
Cannon, CP
CLINICAL CARDIOLOGY, 2003, 26 (09) : 401 - 406
[24] NOVEL ANTITHROMBOTIC THERAPEUTICS TARGETED AGAINST PLATELET GLYCOPROTEIN IIB/IIIA
COUTRE, S
LEUNG, L
ANNUAL REVIEW OF MEDICINE, 1995, 46 : 257 - 265
[25] Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy
Billheimer, JT
He, BK
Spitz, SM
Stern, AM
Seiffert, D
THROMBOSIS RESEARCH, 2002, 107 (06) : 303 - 317
[26] Comparative efficacy between the glycoprotein IIb/IIIa antagonists roxifiban and orbofiban in inhibiting platelet responses in flow models of thrombosis
Mousa, SA
Abulencia, JP
McCarty, OJT
Turner, NA
Konstantopoulos, K
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (04) : 552 - 560
[27] Oral platelet glycoprotein IIb/IIIa receptor inhibitors - Part I
Cannon, CP
CLINICAL CARDIOLOGY, 2003, 26 (08) : 358 - 364
[28] ROLE OF THE PLATELET INTEGRIN GLYCOPROTEIN-IIB-IIIA IN INTRACELLULAR SIGNALING
JACKSON, SP
YUAN, YP
SCHOENWAELDER, SM
MITCHELL, CA
THROMBOSIS RESEARCH, 1993, 71 (02) : 159 - 168
[29] Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release
Chakrabarti, S
Clutton, P
Varghese, S
Cox, D
Mascelli, MA
Freedman, JE
THROMBOSIS RESEARCH, 2004, 113 (3-4) : 225 - 233
[30] Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets
Jeske, WP
Walenga, JM
Szatkowski, E
Ero, M
Herbert, JM
Haas, S
Bakhos, M
THROMBOSIS RESEARCH, 1997, 88 (03) : 271 - 281

← 1 2 3 4 5 →